Empagliflozin Improves the MicroRNA Signature of Endothelial Dysfunction in Patients with Heart Failure with Preserved Ejection Fraction and Diabetes
Pasquale Mone, Angela Lombardi, Urna Kansakar, Fahimeh Varzideh, Stanislovas S. Jankauskas, Antonella Pansini, Stefania Marzocco, Stefano De Gennaro, Michele Famiglietti, Gaetano Macina, Salvatore Frullone, Gaetano Santulli
Topics & Concepts
EmpagliflozinMedicineHeart failure with preserved ejection fractionMetforminInternal medicineEndothelial dysfunctionDiabetes mellitusEjection fractionCardiologyType 2 diabetesHeart failuremicroRNAInsulinEndocrinologyBiologyBiochemistryGeneDiabetes Treatment and ManagementMetabolism, Diabetes, and CancerMicroRNA in disease regulation